亚太地区流感疫苗市场预测至 2028 年 - COVID-19 影响和区域分析 - 按疫苗类型（四价疫苗和三价疫苗）、病毒类型（A 型流感病毒和 B 型流感病毒）、技术（蛋类）基于和基于细胞）、给药途径（注射和鼻喷雾）和目标群体（婴儿、儿童、成人和老年人）
No. of Pages: 166 | Report Code: BMIRE00027310 | Category: Life Sciences
No. of Pages: 166 | Report Code: BMIRE00027310 | Category: Life Sciences
亚太流感疫苗市场预计将从2022年的16.8807亿美元增长到2028年的26.6927亿美元；预计 2022 年至 2028 年复合年增长率为 6.9%。
预测期内新兴经济体将推动亚太流感疫苗市场
亚太流感疫苗市场的领先企业致力于通过扩大分销网络和增强制造能力来扩大新兴市场的客户覆盖范围。随着该地区的成熟，参与者正在将重点转向新兴经济体。由于法规和数据要求不那么严格，亚太地区已成为商业友好且适应性强的中心。此外，新兴国家对生命科学和医疗保健研究的高投资对发展中国家最新技术的升级发挥着至关重要的作用，这支持了先进疫苗开发的倾向。由于印度和韩国的患者群体庞大、流感患病率高、医疗基础设施激增、可支配收入增加以及医疗旅游业激增，预计印度和韩国的流感疫苗主要生产商在未来几年将迎来利润丰厚的机会。
亚太地区流感疫苗市场概览
亚太地区 (APAC) 是流感疫苗增长最快的区域市场。亚太地区流感疫苗市场分为中国、印度、日本、韩国、澳大利亚和亚太地区其他地区。由于政府加强对流感疫苗接种的支持和监测，该地区主要市场参与者的投资增加，导致该地区流感流行和发病率增加。预计这些因素将在未来几年推动亚太地区流感疫苗市场的发展。
亚太地区流感疫苗市场 2028 年收入及预测（百万美元）
< span>
亚太地区流感疫苗市场细分
< span>亚太流感疫苗市场分为疫苗类型、病毒类型、技术、给药途径、目标群体和国家。
根据疫苗类型，亚太流感疫苗市场分为四价疫苗和三价疫苗。 2022年四价疫苗市场占有较大份额。
根据病毒类型，亚太流感疫苗市场分为A型流感病毒和流感病毒型B. 2022年，A型流感病毒将占据更大的市场份额。
根据技术，亚太流感疫苗市场分为蛋基流感疫苗和细胞流感疫苗-基于。到2022年，鸡蛋类疫苗将占据更大的市场份额。
根据给药途径，亚太流感疫苗市场分为注射剂和鼻喷雾剂。 2022年，注射剂细分市场将占据更大份额。
根据目标人群，亚太流感疫苗市场分为婴儿、儿童、成人和老年人。 2022年，婴儿细分市场占据最大市场份额。
按国家/地区划分，亚太流感疫苗市场分为中国、日本、印度、韩国、澳大利亚，以及亚太地区其他地区。 2022 年中国将主导市场。
阿斯利康；紧急生物解决方案公司；葛兰素史克公司；华兰生物工程股份有限公司；三菱化学集团公司；摩德纳公司；迈兰公司；赛诺菲； SEQIRUS；和印度血清研究所列兵。有限公司是亚太流感疫苗市场的领先公司。
Strategic insights for Asia Pacific Influenza Vaccines involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 1,688.07 Million |
| Market Size by 2028 | US$ 2,669.27 Million |
| Global CAGR (2022 - 2028) | 6.9% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 疫苗类型
|
| Regions and Countries Covered | 亚太地区
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific Influenza Vaccines refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Influenza Vaccines Market is valued at US$ 1,688.07 Million in 2022, it is projected to reach US$ 2,669.27 Million by 2028.
As per our report Asia Pacific Influenza Vaccines Market, the market size is valued at US$ 1,688.07 Million in 2022, projecting it to reach US$ 2,669.27 Million by 2028. This translates to a CAGR of approximately 6.9% during the forecast period.
The Asia Pacific Influenza Vaccines Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Influenza Vaccines Market report:
The Asia Pacific Influenza Vaccines Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Influenza Vaccines Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Influenza Vaccines Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Influenza Vaccines Market
